Portfolio company
Stallergenes Greer
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops and manufactures allergen immunotherapy products for healthcare professionals treating patients with respiratory, food, and animal-related allergies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Desentum
This biopharmaceutical company develops allergen immunotherapy products to treat patients suffering from respiratory and food allergies.
Alladapt Immunotherapeutics
This biopharmaceutical company develops oral immunotherapies for patients with single or multiple food allergies to reduce the severity of allergic reactions.
Resistentia Pharmaceuticals AB
This company develops immunotherapeutic products for patients suffering from allergic asthma and inflammatory disorders.
Aiolos Bio
This biopharmaceutical company develops monoclonal antibody therapies for patients suffering from respiratory and inflammatory conditions such as moderate-to-severe asthma.
ANERGIS SA
Anergis SA develops ultra-fast synthetic vaccines to treat patients suffering from frequent environmental allergies such as birch pollen and house dust mites.
Tolergyx
This company develops gastrointestinal immunotherapy capsules to treat food allergies in pediatric and adult patients.
Allergios
This company develops a cell-based diagnostic platform for clinicians to perform precise in vitro allergy tests using blood samples and automated visual analysis.
ARS Pharmaceuticals
ARS Pharmaceuticals develops a needle-free nasal spray for patients and caregivers to treat severe allergic reactions, including anaphylaxis.
